Biochemical brain markers in excited delirium deaths

TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law

Volumn , Issue , 2009, Pages 365-377

  Mash, Deborah C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955860485     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-85475-5_29     Document Type: Chapter

References (44)

1. Satel SL, Seibyl JP, Charney DS. Prolonged cocaine psychosis implies underlying major psychopathology. J Clin Psychiatry 1991;52:349-50.
2. Satel SL, Southwick SM, Gawin FH. Clinical features of cocaine-induced paranoia. Am J Psychiatry 1991;148:495-8.
3. Angrist BM. Cocaine in the context of prior central nervous system stimulant epidemics. In: Volkow N, Swann AC, eds. Cocaine in the Brain (Mind in Medicine Series): Rutgers University Press, 1990:7-24.
4. Wetli CV, Fishbain DA. Cocaine-induced psychosis and sudden death in recreational cocaine users. J Forensic Sci 1985;30:873-80.
5. Wetli CV. Excited delirium. In: Payne-James J, et al., eds. Encyclopedia of Forensic and Legal Medicine. Elsevier, 2005:276-281.
6. Wetli CV, Mash D, Karch SB. Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. Am J Emerg Med 1996;14:425-8.
7. Ruttenber AJ, Lawler-Heavner J, Yin M, Wetli CV, Hearn WL, Mash DC. Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. J Forensic Sci 1997;42:25-31.
8. Ross DL. Factors associated with excited delirium deaths in police custody. Mod Pathol 1998;11:1127-37.
9. Reay DT, Howard JD, Fligner CL, Ward RJ. Effects of positional restraint on oxygen saturation and heart rate following exercise. Am J Forensic Med Pathol 1988;9:16-8.
10. Karch SB, Stephens BG. Drug abusers who die during arrest or in custody. J R Soc Med 1999;92:110-3.
11. Stratton SJ, Rogers C, Brickett K, Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med 2001;19:187-91.
12. Di Maio TG, Di Maio V J M. Excited Delirium Syndrome: Cause of Death and Prevention. Taylor and Francis, New York, 2006.
13. Bell LV. On a form of disease resembling some advanced stages of mania and fever. Am J Insanity 1849;6:97-127.
14. Wetli CV, Natarajan GA. CUSTODY | Death in, United States of America. In: Payne-James J, Byard R, Corey T, Henderson C, eds. Encyclopedia of Forensic and Legal Medicine. Elsevier, 2005:65-73.
15. Kosten TR, Kleber HD. Rapid death during cocaine abuse: a variant of the neuroleptic malignant syndrome? Am J Drug Alcohol Abuse 1988;14:335-46.
16. Friedman JH, Feinberg SS, Feldman RG. A neuroleptic malignant-like syndrome due to levodopa therapy withdrawal. Jama 1985;254:2792-5.
17. Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985;142:1137-45.
18. Caroff SN, Campbell EC, Sullivan KA. Neuroleptic malignant syndrome in elderly patients. Expert Rev Neurother 2007;7:423-31.
19. Strawn JR, Keck PE, Jr., Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007;164:870-6.
20. Stephens BG, Jentzen JM, Karch S, Mash DC, Wetli CV. Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death. Am J Forensic Med Pathol 2004;25:1-10.
21. Stephens BG, Jentzen JM, Karch S, Wetli CV, Mash DC. National Association of Medical Examiners position paper on the certification of cocaine-related deaths. Am J Forensic Med Pathol 2004;25:11-3.
22. Ruttenber AJ, McAnally HB, Wetli CV. Cocaine-associated rhabdomyolysis and excited delirium: different stages of the same syndrome. Am J Forensic Med Pathol 1999;20:120-7.
23. Staley JK, Hearn WL, Ruttenber AJ, Wetli CV, Mash DC. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 1994;271:1678-85.
24. Staley JK, Boja JW, Carroll FI, Seltzman HH, Wyrick CD, Lewin AH, Abraham P, Mash DC. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121. Synapse 1995;21:364-72.
25. Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users. J Neurochem 2002;81:292-300.
26. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987;237:1219-23.
27. Mortensen OV, Amara SG. Dynamic regulation of the dopamine transporter. Eur J Pharmacol 2003;479:159-70.
28. Uhl GR. Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism. Mov Disord 2003;18 Suppl 7:S71-80.
29. Riddle EL, Fleckenstein AE, Hanson GR. Role of monoamine transporters in mediating psychostimulant effects. Aaps J 2005;7:E847-51.
30. Pristupa ZB, Wilson JM, Hoffman BJ, Kish SJ, Niznik HB. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35, 428 and [3H]GBR 12, 935 binding. Mol Pharmacol 1994;45:125-35.
31. Gelernter J, Kranzler HR, Satel SL, Rao PA. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 1994;11:195-200.
32. van Dyck CH, Quinlan DM, Cretella LM, Staley JK, Malison RT, Baldwin RM, Seibyl JP, Innis RB. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatry 2002;159:309-12.
33. van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin RM, Innis RB, Gelernter J. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 2005;46:745-51.
34. Boden AG, Harris MC, Parkes MJ. The preoptic area in the hypothalamus is the source of the additional respiratory drive at raised body temperature in anaesthetised rats. Exp Physiol 2000;85:527-37.
35. Costentin J, Duterte-Boucher D, Panissaud C, Michael-Titus A. Dopamine D1 and D2 receptors mediate opposite effects of apomorphine on the body temperature of reserpinized mice. Neuropharmacology 1990;29:31-5.
36. Meller E, Hizami R, Kreuter L. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors. Pharmacol Biochem Behav 1989;32:141-5.
37. Peris J, Boyson SJ, Cass WA, Curella P, Dwoskin LP, Larson G, Lin LH, Yasuda RP, Zahniser NR. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther 1990;253:38-44.
38. Kleven MS, Perry BD, Woolverton WL, Seiden LS. Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain. Brain Res 1990;532:265-70.
39. Nunes JL, Sharif NA, Michel AD, Whiting RL. Dopamine D2-receptors mediate hypothermia in mice: ICV and IP effects of agonists and antagonists. Neurochem Res 1991;16:1167-74.
40. Barros RC, Branco LG, Carnio EC. Evidence for thermoregulation by dopamine D1 and D2 receptors in the anteroventral preoptic region during normoxia and hypoxia. Brain Res 2004;1030:165-71.
41. Wang ZZ, Wang CL, Wu TC, Pan HN, Wang SK, Jiang JD. Autoantibody response to heat shock protein 70 in patients with heatstroke. Am J Med 2001;111:654-7.
42. Crandall CG, Vongpatanasin W, Victor RG. Mechanism of cocaine-induced hyperthermia in humans. Ann Intern Med 2002;136:785-91.
43. Skidmore R, Gutierrez JA, Guerriero V, Jr., Kregel KC. HSP70 induction during exercise and heat stress in rats: role of internal temperature. Am J Physiol 1995;268:R92-7.
44. Kregel KC. Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 2002;92:2177-86.